✦ LIBER ✦

Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer

✍ Scribed by Budach, V.; Becker, E.-T.; Boehmer, D.; Badakhshi, H.; Jahn, U.; Wernecke, K.-D.; Stromberger, C.

Book ID: 121591681
Publisher: Springer
Year: 2013
Tongue: German
Weight: 617 KB
Volume: 190
Category: Article
ISSN: 0179-7158
DOI: 10.1007/s00066-013-0481-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperfractionated accelerated radiothera

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

✍ Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB 👁 2 views

## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de

8534 Hyperfractionated radiotherapy with

8534 Hyperfractionated radiotherapy with concurrent docetaxel in locally-advanced head and neck cancer

✍ Karasawa, K.; Izawa, H.; Hirowatari, H.; Ito, K.; Furuya, T.; Ozawa, S.; Matsumo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Weekly and 3-weekly cisplatin concurrent

Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer

✍ V. Espeli; E. Zucca; M. Ghielmini; O. Giannini; A. Salatino; F. Martucci; A. Ric 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Six-fractions-a-week radiotherapy along

Six-fractions-a-week radiotherapy along with concurrent weekly cisplatin in locally advanced head and neck cancer

✍ S. Kumar; R. Bajpai; N. Rastogi; K.J. Maria Das; P. Lai 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Weekly 5-fluorouracil plus cisplatin for

Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer

✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we

Concomitant weekly cisplatin and altered

Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer

✍ Heather E. Newlin; Robert J. Amdur; Charles E. Riggs; Christopher G. Morris; Jes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## Abstract ## BACKGROUND: Both concomitant chemotherapy and altered fractionation radiotherapy (RT) have been shown to improve outcomes for patients with locoregionally advanced head and neck squamous cell carcinomas. However, both strategies also increase acute toxicity, and it is questionable w